FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4781011000001101: Daclizumab 25mg/5ml solution for injection vials 3 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21408901000001110 Daclizumab 25mg/5ml solution for injection vials 3 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52565001000001116 Daclizumab 25mg/5ml solution for infusion vials 3 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclizumab 25mg/5ml solution for injection vials 3 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Is pack of Daclizumab 25mg/5mL infusion concentrate false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has active ingredient Daclizumab false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has VMP Daclizumab 25mg/5mL infusion concentrate false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has specific active ingredient Daclizumab true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has VMP Daclizumab 25mg/5ml solution for infusion vials false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has VMP Daclizumab 25mg/5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) 3 vial 3 x 5ml vials Is a True Daclizumab 25mg/5ml solution for injection vials 3 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start